BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3233622)

  • 1. Heart failure today.
    Opie LH
    Cardiology; 1988; 75 Suppl 1():155-8. PubMed ID: 3233622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ibopamine in treatment of mild heart failure, a comparison with hydrochlorothiazide].
    Kleber FX; Thyroff-Friesinger U
    Z Kardiol; 1991; 80 Suppl 8():113. PubMed ID: 1796629
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ibopamine--clinical results].
    Kleber FX
    Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
    Itoh H; Taniguchi K; Tsujibayashi T; Koike A; Sato Y; Nakamura S
    Cardiology; 1992; 80(5-6):356-66. PubMed ID: 1451123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F; Morgera T; Maras P; Camerini F
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibopamine--how should it be used?
    Bussmann WD; Wienhöfer K; Frik R
    Cardiology; 1988; 75 Suppl 1():126-37. PubMed ID: 3069210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpharzam medical forum--'heart failure today'.
    Cardiology; 1988; 75 Suppl 1():148-54. PubMed ID: 3069211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T; Isaka N; Konishi T; Tekezawa H; Morimoto Y; Kakuta Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
    López-Sendón J
    Cardiology; 1990; 77 Suppl 5():9-21. PubMed ID: 1980634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inotropic agents in the treatment of congestive heart failure].
    Hutton I; McKillop J; Clark R; Martin W; Tweddel A
    Ter Arkh; 1982; 54(11):98-101. PubMed ID: 7157176
    [No Abstract]   [Full Text] [Related]  

  • 16. [New aspects for therapy of chronic heart failure with positive inotropic substances].
    Erdmann E
    Verh Dtsch Ges Inn Med; 1991; 97():178-84. PubMed ID: 1808882
    [No Abstract]   [Full Text] [Related]  

  • 17. Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study.
    Azzolini A; Guffanti E; Ronzitti M; Tantalo L; Colantoni A; Pizzorni C
    Cardiology; 1990; 77 Suppl 5():89-95. PubMed ID: 2279258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of heart failure. Take the chance!].
    Einecke D
    MMW Fortschr Med; 2001 Sep; 143(38):8-10, 12. PubMed ID: 11601101
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug of the month. Ibopamine (Scandine, Idopamil)].
    Scheen AJ
    Rev Med Liege; 1994 Jun; 49(6):365-6. PubMed ID: 8047755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.